The “2022 Cellular Therapy Conference” is a CME-accredited activity with in-person and virtual formats featuring leading experts in cellular therapies. The goal of this activity is to improve the knowledge, competence, and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients receiving cellular therapies for hematologic and non-hematologic disorders. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in chimeric antigen receptor (CAR) based therapies. Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.
